CN108913647B - 一种干细胞培养基及其制备方法 - Google Patents
一种干细胞培养基及其制备方法 Download PDFInfo
- Publication number
- CN108913647B CN108913647B CN201810898296.1A CN201810898296A CN108913647B CN 108913647 B CN108913647 B CN 108913647B CN 201810898296 A CN201810898296 A CN 201810898296A CN 108913647 B CN108913647 B CN 108913647B
- Authority
- CN
- China
- Prior art keywords
- growth factor
- culture medium
- acid solution
- microspheres
- chitosan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 39
- 239000006143 cell culture medium Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000004005 microsphere Substances 0.000 claims abstract description 71
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims abstract description 40
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims abstract description 40
- 229940126864 fibroblast growth factor Drugs 0.000 claims abstract description 38
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims abstract description 36
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000001963 growth medium Substances 0.000 claims abstract description 30
- SJDMTGSQPOFVLR-UHFFFAOYSA-N [10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] tetradecanoate Chemical compound C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCC)C2 SJDMTGSQPOFVLR-UHFFFAOYSA-N 0.000 claims abstract description 28
- 102000004877 Insulin Human genes 0.000 claims abstract description 18
- 108090001061 Insulin Proteins 0.000 claims abstract description 18
- 229940125396 insulin Drugs 0.000 claims abstract description 18
- 235000021314 Palmitic acid Nutrition 0.000 claims abstract description 17
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000000654 additive Substances 0.000 claims abstract description 15
- 241000237536 Mytilus edulis Species 0.000 claims abstract description 14
- 102000004338 Transferrin Human genes 0.000 claims abstract description 14
- 108090000901 Transferrin Proteins 0.000 claims abstract description 14
- 229940089161 ginsenoside Drugs 0.000 claims abstract description 14
- 229930182494 ginsenoside Natural products 0.000 claims abstract description 14
- 235000020638 mussel Nutrition 0.000 claims abstract description 14
- 239000012581 transferrin Substances 0.000 claims abstract description 14
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 claims abstract description 8
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 claims abstract description 8
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 claims abstract description 8
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229920002414 procyanidin Polymers 0.000 claims abstract description 8
- 238000013268 sustained release Methods 0.000 claims abstract description 6
- 239000012730 sustained-release form Substances 0.000 claims abstract description 6
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims abstract description 3
- 101800003838 Epidermal growth factor Proteins 0.000 claims abstract description 3
- 229940116977 epidermal growth factor Drugs 0.000 claims abstract description 3
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims abstract description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 81
- 229920001661 Chitosan Polymers 0.000 claims description 37
- 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 claims description 28
- 229940116978 human epidermal growth factor Drugs 0.000 claims description 28
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 claims description 28
- 238000003756 stirring Methods 0.000 claims description 24
- 230000010261 cell growth Effects 0.000 claims description 17
- 239000003102 growth factor Substances 0.000 claims description 17
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 14
- 210000001339 epidermal cell Anatomy 0.000 claims description 10
- 238000011068 loading method Methods 0.000 claims description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 8
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 claims description 8
- 238000004108 freeze drying Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- 229940005657 pyrophosphoric acid Drugs 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 8
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 8
- 229960003495 thiamine Drugs 0.000 claims description 8
- 235000019157 thiamine Nutrition 0.000 claims description 8
- 239000011721 thiamine Substances 0.000 claims description 8
- 238000001132 ultrasonic dispersion Methods 0.000 claims description 8
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000009630 liquid culture Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 abstract description 26
- 210000002966 serum Anatomy 0.000 abstract description 7
- 241001465754 Metazoa Species 0.000 abstract description 6
- 238000004113 cell culture Methods 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 17
- 239000002609 medium Substances 0.000 description 15
- 239000007640 basal medium Substances 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 230000012010 growth Effects 0.000 description 7
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 7
- 230000035755 proliferation Effects 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 238000000684 flow cytometry Methods 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920001991 Proanthocyanidin Polymers 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810898296.1A CN108913647B (zh) | 2018-08-08 | 2018-08-08 | 一种干细胞培养基及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810898296.1A CN108913647B (zh) | 2018-08-08 | 2018-08-08 | 一种干细胞培养基及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108913647A CN108913647A (zh) | 2018-11-30 |
CN108913647B true CN108913647B (zh) | 2021-06-04 |
Family
ID=64394647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810898296.1A Active CN108913647B (zh) | 2018-08-08 | 2018-08-08 | 一种干细胞培养基及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108913647B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110713974A (zh) * | 2019-11-25 | 2020-01-21 | 深圳科学之门生物工程有限公司 | 一种干细胞培养基及其制备方法 |
CN114350596B (zh) * | 2022-02-17 | 2023-11-10 | 浙江卫未生物医药科技有限公司 | 一种毛囊外根鞘细胞培养基 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102988964A (zh) * | 2012-11-02 | 2013-03-27 | 广州军区广州总医院 | 一种复合生长因子及其制备方法与应用 |
CN103243070A (zh) * | 2013-04-25 | 2013-08-14 | 刘小青 | 一种干细胞培养基及其应用 |
CN104840428A (zh) * | 2014-02-13 | 2015-08-19 | 山东省生物医药科学院 | 一种载有表皮生长因子的透明质酸-壳聚糖微球及其制备方法和应用 |
CN106635957A (zh) * | 2016-12-23 | 2017-05-10 | 叶宗耀 | 一种干细胞培养基及其制备方法 |
CN107022521A (zh) * | 2017-02-13 | 2017-08-08 | 广东唯泰生物科技有限公司 | 壁蜕膜组织冻存、复苏及分离培养间充质干细胞的方法 |
CN107267462A (zh) * | 2017-08-07 | 2017-10-20 | 广州润虹医药科技股份有限公司 | 一种诱导多能干细胞快速产生的无血清培养基 |
CN107397710A (zh) * | 2017-07-31 | 2017-11-28 | 广州润虹医药科技股份有限公司 | 一种皮肤干细胞活性素的制备方法及其应用 |
KR20180008015A (ko) * | 2016-07-15 | 2018-01-24 | 주식회사 엔바이오텍 | 줄기세포 배양용 무혈청 배지 조성물 및 이를 이용한 줄기세포의 배양 방법 |
KR101878441B1 (ko) * | 2017-02-14 | 2018-07-16 | 경상대학교산학협력단 | 신생아 말초혈액 유래 중간엽 줄기세포의 분리 및 배양 방법 |
CN109576222A (zh) * | 2017-09-29 | 2019-04-05 | 重庆金时代生物技术有限公司 | 一种造血干细胞培养基 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101766837B (zh) * | 2009-12-28 | 2013-03-27 | 中国人民解放军第二炮兵总医院 | 仿生多孔微球组织工程支架及其制作方法 |
KR20180058430A (ko) * | 2016-11-24 | 2018-06-01 | 가톨릭대학교 산학협력단 | 생리활성물질을 함유하는 풀루란 아세테이트 미립구 및 이의 제조방법 |
CN108042497A (zh) * | 2018-01-23 | 2018-05-18 | 董玉珍 | 一种NT-3转染BMSCs纳米微球控释体的制备方法及其应用 |
-
2018
- 2018-08-08 CN CN201810898296.1A patent/CN108913647B/zh active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102988964A (zh) * | 2012-11-02 | 2013-03-27 | 广州军区广州总医院 | 一种复合生长因子及其制备方法与应用 |
CN103243070A (zh) * | 2013-04-25 | 2013-08-14 | 刘小青 | 一种干细胞培养基及其应用 |
CN104840428A (zh) * | 2014-02-13 | 2015-08-19 | 山东省生物医药科学院 | 一种载有表皮生长因子的透明质酸-壳聚糖微球及其制备方法和应用 |
KR20180008015A (ko) * | 2016-07-15 | 2018-01-24 | 주식회사 엔바이오텍 | 줄기세포 배양용 무혈청 배지 조성물 및 이를 이용한 줄기세포의 배양 방법 |
CN106635957A (zh) * | 2016-12-23 | 2017-05-10 | 叶宗耀 | 一种干细胞培养基及其制备方法 |
CN107022521A (zh) * | 2017-02-13 | 2017-08-08 | 广东唯泰生物科技有限公司 | 壁蜕膜组织冻存、复苏及分离培养间充质干细胞的方法 |
KR101878441B1 (ko) * | 2017-02-14 | 2018-07-16 | 경상대학교산학협력단 | 신생아 말초혈액 유래 중간엽 줄기세포의 분리 및 배양 방법 |
CN107397710A (zh) * | 2017-07-31 | 2017-11-28 | 广州润虹医药科技股份有限公司 | 一种皮肤干细胞活性素的制备方法及其应用 |
CN107267462A (zh) * | 2017-08-07 | 2017-10-20 | 广州润虹医药科技股份有限公司 | 一种诱导多能干细胞快速产生的无血清培养基 |
CN109576222A (zh) * | 2017-09-29 | 2019-04-05 | 重庆金时代生物技术有限公司 | 一种造血干细胞培养基 |
Non-Patent Citations (3)
Title |
---|
Engineering vascularized soft tissue flaps in an animal model using human adipose derived stem cells and VEGF plus PLGA/PEG microspheres on a collagen-chitosan scaffold with a flow-through vascular pedicle;Qixu Zhang等;《BIOMATERIALS》;20150918;第73卷;第198-213页 * |
体外壳聚糖-明胶-生长因子缓释支架对骨髓间充质干细胞增殖的影响;戴芳等;《材料科学与工程学报》;20110820;第29卷(第4期);第605-609页 * |
神经生长因子壳聚糖和PLGA微球缓释效能的对比;高琦等;《南昌大学学报(医学版)》;20171228;第57卷(第6期);第12-16页 * |
Also Published As
Publication number | Publication date |
---|---|
CN108913647A (zh) | 2018-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106754670B (zh) | 一种间充质干细胞无血清培养基及其配制方法和应用 | |
US20080009064A1 (en) | Temperature-Responsive Microcarrier | |
CN108913647B (zh) | 一种干细胞培养基及其制备方法 | |
CN112889813B (zh) | 一种细胞存活率高的人脐带间充质干细胞的冻存方法 | |
CN112592890A (zh) | 一种促进肌肉干细胞增殖的方法 | |
CN114557337B (zh) | 脐带间充质干细胞无蛋白非程序冻存液及其制备方法 | |
CN109370985A (zh) | 一种人脐带间充质干细胞大规模培养无血清培养基 | |
CN111440764B (zh) | 间充质干细胞的无血清培养基及间充质干细胞的临床级规模化培养方法 | |
CN106942203B (zh) | 一种ips细胞保存液及其制备方法 | |
CN114480286A (zh) | 无血清悬浮型lmh细胞系及其制备方法和应用 | |
US20090233360A1 (en) | Methods and Compositions for Culturing of neural Precursor Cells | |
CN112608884B (zh) | 培养基补充组合物、干细胞培养基及其制备方法 | |
CN111748527B (zh) | 化学成分限定高效补料培养基及其制备方法和应用 | |
CN110734893B (zh) | 含维生素c的促进脐带间充质干细胞增殖的培养基 | |
CN110669730B (zh) | 一种人外周血淋巴细胞培养基 | |
CN112779220B (zh) | 一种用于神经干细胞扩增的培养基 | |
CN109266600A (zh) | 一种成纤维细胞的培养基及利用其培养成纤维细胞的方法 | |
CN112425603B (zh) | 一种脂肪干细胞运输保存液 | |
CN106754678A (zh) | 一种适用于牙髓干细胞体外培养的培养基及其制备方法 | |
CN102653729A (zh) | 一种用于中国仓鼠卵巢细胞的培养基 | |
CN109385398B (zh) | 一种化学成分确定的细胞培养基及其应用 | |
CN114075540A (zh) | 全化学成分hek293细胞培养基及其应用 | |
CN111849863A (zh) | 支持cho细胞高效生产单克隆抗体的培养基添加剂及其制备方法和应用 | |
CN106244544A (zh) | 一种dc细胞无血清培养基 | |
Tong | [75] The isolation and culture of thyroid cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231215 Address after: 530299 Nanning, Guangxi Zhuang Autonomous Region China (Guangxi) Pilot Free Trade Zone Nanning Area Wuxiang Avenue No. 403, Building G1, 688th Floor, Fuya International Financial Center No. 6801, 6802, 6803, 6810, 6811, 6812, 6813, 6815, 6816, 6817 Patentee after: Guangxi Ruijian Biotechnology Co.,Ltd. Address before: Room 206-8, Building 1, Tianyuan Free Trade Port, No. 202 Heluo Road, High tech Zone, Luoyang Area, China (Henan) Pilot Free Trade Zone, Luoyang City, Henan Province, 471000 Patentee before: Luoyang Xiangzhi Intellectual Property Service Co.,Ltd. Effective date of registration: 20231215 Address after: Room 206-8, Building 1, Tianyuan Free Trade Port, No. 202 Heluo Road, High tech Zone, Luoyang Area, China (Henan) Pilot Free Trade Zone, Luoyang City, Henan Province, 471000 Patentee after: Luoyang Xiangzhi Intellectual Property Service Co.,Ltd. Address before: 453003 Xinxiang Medical College, 601 Jinsui Avenue, Xinxiang City, Henan Province Patentee before: XINXIANG MEDICAL University |